AceLink is advancing a small-molecule treatment option for Fabry disease, which could provide a more convenient alternative ...

Nanotechnology, a groundbreaking field that involves manipulating matter at the molecular and atomic levels, is rapidly ...

As part of its continued commitment to developing next-generation cancer therapeutics, Ocean Biomedical is initiating ...

TScan Therapeutics is developing engineered T cell receptor therapies, with TSC-101 targeting HA-2 for acute leukemia. See ...

Preclinical studies have shown their potential to reduce inflammation and modulate immune responses in diseases like rheumatoid arthritis and lupus.

Using “cure” to refer to “obtaining a normal life” also fits — if you ignore previously lost education, career opportunities ...

A Pinterest post claims that Onion, Banana and Turmeric drink Can Cure Arthritis in 3 Days. The claim by the user is ...

Successful detection of brain metastases using RAD 101 (18F-Pivalate) in a novel multiparametric imaging methodology ...

Fentanyl Act. The bill aims to make permanent a Drug Enforcement Administration (DEA) temporary emergency rule from 2018, ...

It is closely associated with tumorigenesis and drug resistance, making it a potential target for oncology drug development. To date, no ROR1-targeting drugs have been marketed. BR111 utilizes ...

To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...

Stifel analysts confirmed their Buy rating on Denali Therapeutics Inc. (NASDAQ:DNLI) with a steady price target of $37.00. According to InvestingPro data, analysts maintain a Strong Buy consensus with ...